Video Experimental Relacionado
Updated: Jul 26, 2026
09:12
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Los efectos relativos de la hipertrofia ventricular izquierda, la enfermedad de las arterias coronarias y la
Y Liao1, R S Cooper, D L McGee
1Department of Preventive Medicine and Epidemiology, Loyola University Medical Center, Maywood, Ill 60153, USA.
JAMA
|May 24, 1995
Resumen
La hipertrofia ventricular izquierda (LVH) afecta significativamente la supervivencia más que la gravedad de la enfermedad de la arteria coronaria en pacientes negros. Este hallazgo destaca la LVH como un factor de riesgo crítico e independiente para resultados adversos en enfermedades del corazón.
Área de la Ciencia:
- Cardiología Cardiología.
- Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular Investigación Cardiovascular
- La medicina clínica es la medicina clínica.
Sus antecedentes:
- La hipertrofia ventricular izquierda (LVH) es una adaptación cardíaca común.
- Su importancia pronóstica en relación con la gravedad de la enfermedad de las arterias coronarias (CAD) requiere una mayor aclaración.
- Comprender estos factores es crucial para la gestión del riesgo cardiovascular, particularmente en poblaciones específicas.
Objetivo del estudio:
- Para comparar el impacto de la LVH determinada por ecocardiografía en la supervivencia.
- Evaluar el efecto de la LVH contra el número de vasos coronarios estenosados y la disfunción sistólica ventricular izquierda.
- Evaluar la LVH como un predictor independiente de la mortalidad en una cohorte de pacientes negros.
Principales métodos:
- Se realizó un estudio de cohorte utilizando una muestra consecutiva de un registro hospitalario.
- 1089 pacientes negros se sometieron a angiografía coronaria y ecocardiografía.
- El seguimiento promedio fue de 5 años, con análisis que incluyeron modelos multivariados.
Principales resultados:
- La LVH se detectó en el 50% de los pacientes.
- La LVH confería un riesgo relativo (RR) de 2.4 para la mortalidad, superior al de la enfermedad multivascular (RR 1.6) y la disfunción ventricular (RR 2.0).
- LVH representó de forma independiente el 37% de las muertes en la cohorte, significativamente más alto que otros factores.
Conclusiones:
- La hipertrofia ventricular izquierda es un predictor más fuerte de la mortalidad que las medidas tradicionales de la gravedad de la enfermedad coronaria.
- La alta prevalencia y el riesgo potente asociados con LVH contribuyen significativamente a las tasas de supervivencia adversas en pacientes negros con enfermedad cardíaca.
- La LVH puede explicar una parte sustancial de las disparidades observadas en blanco y negro en los resultados cardiovasculares.
Más Videos Relacionados
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Videos de Conceptos Relacionados
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...